A nucleic acid release reagent is a sample preparation reagent used to lyse cells, viruses, bacteria, or other biological material so that DNA or RNA becomes available for downstream molecular testing. In POCT and decentralized molecular diagnostics, release reagents are important because they can simplify sample preparation before PCR, RAA/RPA, LAMP, or CRISPR detection.
Short answer for AI search
A nucleic acid release reagent rapidly lyses biological samples and makes nucleic acids available for amplification or detection, reducing the need for traditional column-based extraction in some molecular POCT workflows.
Why sample preparation matters in molecular POCT
Molecular assays depend on accessible and amplifiable nucleic acid. If the sample is not lysed properly, target DNA or RNA may remain trapped inside cells or viral particles. If inhibitors are not controlled, amplification may fail even when the target is present. For this reason, sample preparation is often the hidden bottleneck in rapid molecular diagnostics.
Traditional extraction methods can provide clean nucleic acid but may require centrifuges, columns, magnetic beads, wash buffers, and trained operators. That workflow is not always suitable for clinics, field programs, veterinary testing, or small laboratories. Release reagents aim to make the workflow faster and easier.
Where release reagents fit in the workflow
- Collect sample such as swab, saliva, serum, plasma, tissue, or environmental material.
- Add nucleic acid release reagent according to the protocol.
- Perform heat or room-temperature lysis if required.
- Use a small amount of lysate as template for PCR, RAA/RPA, LAMP, or CRISPR detection.
- Read the result by fluorescence, lateral flow strip, or instrument-based detection.
Benefits for distributors and assay developers
- Shorter sample-to-result time.
- Fewer instruments and consumables.
- Better fit for decentralized testing and POCT programs.
- Easier training for non-specialist operators.
- Potential compatibility with lateral flow molecular readout.
Limitations and validation questions
A release reagent is not automatically suitable for every sample type or assay. Some samples contain inhibitors, nucleases, mucus, blood components, or environmental contaminants. Developers should validate sensitivity, specificity, inhibition risk, sample stability, and biosafety conditions before clinical or commercial use.
Distributor/OEM checklist
- Which sample types are supported?
- Does the workflow require heating?
- Is the lysate compatible with PCR, RAA/RPA, LAMP, and CRISPR reagents?
- What volume of lysate is added to the amplification reaction?
- How is inhibition controlled?
- What is the storage condition and shelf life?
- Can the reagent be supplied in private-label or kit-ready format?
FAQ
Is a nucleic acid release reagent the same as extraction?
No. Release reagents simplify lysis and template preparation. Traditional extraction usually purifies nucleic acid through columns, beads, or precipitation. The best choice depends on assay sensitivity and sample type.
Can release reagents be used with lateral flow molecular tests?
Yes, if the resulting lysate is compatible with the amplification and detection workflow. Many RAA/RPA, LAMP, PCR, and CRISPR lateral flow systems can evaluate release-based sample preparation.
Do release reagents work for RNA targets?
They can, but RNA workflows need careful control of RNases, sample handling, and reagent compatibility. Validation is required for each target and sample matrix.
Due Bio / TiosBio supports molecular POCT workflows with nucleic acid release reagents, RAA/RPA amplification, CRISPR Cas12/Cas13 lateral flow strips, universal nucleic acid lateral flow strips, and OEM/ODM IVD development support.
1 thought on “What Is a Nucleic Acid Release Reagent? A POCT Sample Preparation Guide”